Xiong Yu - Joincare Pharmaceutical President Director

600380 Stock   11.69  0.09  0.76%   

President

Xiong Yu is President Director of Joincare Pharmaceutical Group
Age 63
Address Joincare Pharmaceutical Group Building, Shenzhen, China, 518057
Phone86 75 5862 52368
Webhttps://www.joincare.com

Joincare Pharmaceutical Management Efficiency

The company has return on total asset (ROA) of 0.0544 % which means that it generated a profit of $0.0544 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1332 %, meaning that it generated $0.1332 on every $100 dollars invested by stockholders. Joincare Pharmaceutical's management efficiency ratios could be used to measure how well Joincare Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Joincare Pharmaceutical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 1.9 B, whereas Other Current Assets are forecasted to decline to about 277.4 M.

Similar Executives

Found 1 records

PRESIDENT Age

H TsaiNexchip Semiconductor Corp
N/A
Joincare Pharmaceutical Group (600380) is traded on Shanghai Stock Exchange in China and employs 14,365 people. Joincare Pharmaceutical is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Joincare Pharmaceutical Leadership Team

Elected by the shareholders, the Joincare Pharmaceutical's board of directors comprises two types of representatives: Joincare Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Joincare. The board's role is to monitor Joincare Pharmaceutical's management team and ensure that shareholders' interests are well served. Joincare Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Joincare Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nanqi Lin, VP Director
Shan Zhong, Deputy Mang
Qingfeng Qiu, CFO VP
Lingzhi Tang, Financial Controller
Leiming Zhang, Vice President
Xiong Yu, President Director
Feng Zhao, VP Directors

Joincare Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Joincare Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Joincare Stock

Joincare Pharmaceutical financial ratios help investors to determine whether Joincare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Joincare with respect to the benefits of owning Joincare Pharmaceutical security.